Research organisations join forces to develop treatments for neglected infectious diseases
Two research organisations based in Paris, the Institut de Recherche pour le Développement (Institute of Research for Development) and the Drugs for Neglected Diseases Initiative, have announced that they will work together to develop new candidate drugs to treat visceral leishmaniasis, Chagas’s disease, and sleeping sickness.
The collaboration will focus on the development of two types of molecules: quinolines for visceral leishmaniasis and canthin-6-one alkaloids for Chagas’s disease. Researchers working at the Institut de Recherche pour le Développement have established that these molecules have potential therapeutic activity.
BMJ 2008;336:1396-1397 (21 June), doi:10.1136/bmj.a389, http://www.bmj.com/cgi/content/extract/336/7658/1396-a